Well said. What this stock needs is some clear strategic directions and milestones. Right now it seems to be living from one promise to the next
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025